tiprankstipranks
Advertisement
Advertisement

ANNX Stock Latest News

Annexon Stockholders Approve Directors, Compensation and Share Increase
Company AnnouncementsAnnexon Stockholders Approve Directors, Compensation and Share Increase
20d ago
8K
ANNX
Annexon initiated with a Neutral at Goldman Sachs
PremiumThe Fly
Annexon initiated with a Neutral at Goldman Sachs
2M ago
ANNX
Annexon: Advancing Complement Pipeline and Strong Cash Runway Support Buy Rating; $11 Price Target Reiterated
PremiumRatings
Annexon: Advancing Complement Pipeline and Strong Cash Runway Support Buy Rating; $11 Price Target Reiterated
2M ago
ANNX
Annexon reports Q1 EPS (23c), consensus (30c)
PremiumThe Fly
Annexon reports Q1 EPS (23c), consensus (30c)
2M ago
ANNX
Cyber Risks Threaten Annexon Biosciences’ Clinical Operations, Reputation and Financial Health
PremiumCompany Announcements
Cyber Risks Threaten Annexon Biosciences’ Clinical Operations, Reputation and Financial Health
3M ago
ANNX
Chardan sees positive read-through to Annexon’s vonaprument from Apellis deal
PremiumThe FlyChardan sees positive read-through to Annexon’s vonaprument from Apellis deal
3M ago
ANNX
APLS
Annexon files automatic mixed securities shelf
Premium
The Fly
Annexon files automatic mixed securities shelf
3M ago
ANNX
Annexon: Solid Cash Runway and 2026 Clinical Catalysts Underpin Buy Rating
Premium
Ratings
Annexon: Solid Cash Runway and 2026 Clinical Catalysts Underpin Buy Rating
3M ago
ANNX
Annexon (ANNX): Late‑Stage Complement Pipeline and Strong Cash Runway Support Attractive Risk‑Reward and Buy Rating
PremiumRatings
Annexon (ANNX): Late‑Stage Complement Pipeline and Strong Cash Runway Support Attractive Risk‑Reward and Buy Rating
3M ago
ANNX
Annexon reports Q4 EPS (28c), consensus (32c)
PremiumThe Fly
Annexon reports Q4 EPS (28c), consensus (32c)
3M ago
ANNX
Undervalued Vision Preservation Opportunity: Buy Recommendation on Annexon Driven by Differentiated GA Therapy vonaprument Ahead of Pivotal Phase 3 Data
PremiumRatings
Undervalued Vision Preservation Opportunity: Buy Recommendation on Annexon Driven by Differentiated GA Therapy vonaprument Ahead of Pivotal Phase 3 Data
4M ago
ANNX
ANNX Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
ANNX Upcoming Earnings Report: What to Expect?
4M ago
ANNX
Annexon Biosciences Announces Planned Retirement of Board Chairman
PremiumCompany AnnouncementsAnnexon Biosciences Announces Planned Retirement of Board Chairman
4M ago
8K
ANNX
Annexon Highlights Late-Stage C1q Pipeline and 2026 Outlook
Premium
Company Announcements
Annexon Highlights Late-Stage C1q Pipeline and 2026 Outlook
6M ago
8K
ANNX
Annexon highlights its 2026 strategic priorities
Premium
The Fly
Annexon highlights its 2026 strategic priorities
6M ago
ANNX
Annexon Biosciences outlines pivotal 2026 milestones and outlook
PremiumCompany Announcements
Annexon Biosciences outlines pivotal 2026 milestones and outlook
6M ago
8K
ANNX
Annexon submits MAA to EMA for tanruprubart
PremiumThe Fly
Annexon submits MAA to EMA for tanruprubart
6M ago
ANNX
Vizsla, Coty, Kalaris, Annexon, Brown & Brown Trending
PremiumWeekend Updates
Vizsla, Coty, Kalaris, Annexon, Brown & Brown Trending
6M ago
BRO
ANNX
Annexon initiated with a Buy at Chardan
PremiumThe Fly
Annexon initiated with a Buy at Chardan
6M ago
ANNX
Annexon initiated with a Buy at Clear Street
PremiumThe FlyAnnexon initiated with a Buy at Clear Street
7M ago
ANNX
Annexon price target raised to $27 from $14 at Wells Fargo
Premium
The Fly
Annexon price target raised to $27 from $14 at Wells Fargo
8M ago
ANNX
Annexon price target lowered to $8 from $9 at BofA
Premium
The Fly
Annexon price target lowered to $8 from $9 at BofA
8M ago
ANNX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >